US President Donald Trump has been given a dose of an experimental antibody drug manufactured by giant biopharma firm Regeneron, which has a major plant at Limerick, where it employs over 1,000 people.
The White House announced last night that President Trump had been given a single 8g dose of Regeneron's antibody cocktail REGN-COV2, before he was moved to the Walter Reed National Military Medical Centre in Maryland.
The antibody is being manufactured at its New York facility, but the company announced last month that it was creating an additional 400 jobs at its Limerick campus to allow the company to maximise its capacity at its NY plant, and change how some of its operations work in light of the Covid pandemic.